查看购物车
  • Traditional Chinese
  • English
  • Japanese
核酸样品製备设备市场－全球及区域分析：按产品类型、技术、处理能力、最终使用者和地区划分－分析与预测（2025-2035 年）
市场调查报告书
商品编码
2019015

核酸样品製备设备市场－全球及区域分析：按产品类型、技术、处理能力、最终使用者和地区划分－分析与预测（2025-2035 年）

Nucleic Acid Sample Preparation Instruments Market - A Global and Regional Analysis: Focus on Product Type, Technology, Throughput, End User, and Region - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 191 Pages | 商品交期: 1-5个工作天内

价格

2024 年全球核酸样品製备设备市场初始估值为 9.101 亿美元，但预计将大幅成长，到 2035 年将飙升至 16.018 亿美元，并在 2025 年至 2035 年期间实现 5.10% 的显着复合年增长率。

关键市场统计数据
预测期 2025-2035
2025年市场规模 9.743亿美元
2035年预测 16.018亿美元
复合年增长率 5.1%

在精准快速的分子诊断（尤其是感染疾病、肿瘤生物标记和遗传疾病的检测）需求不断增长的推动下，该市场持续扩张。癌症、病毒感染和罕见遗传感染疾病等疾病负担的日益加重，显着加速了对高效核酸萃取和纯化系统的需求，而这些系统是PCR和次世代定序（NGS）等下游应用的基础。

成长要素之一是自动化和高通量核酸样本製备设备的日益普及。这些设备透过最大限度地减少人工操作、降低人为误差并确保结果的可重复性，从而提高了检查室效率。检查室正朝着整合提取、纯化和分析的全流程工作流程发展，这缩短了检测週转时间，并实现了大规模检测，尤其是在临床和诊断领域。新冠疫情的经验教训进一步强化了这一趋势，凸显了可扩展且可靠的样本製备技术的重要性。

此外，基因组学和个人化医疗的快速发展也显着推动了市场成长。製药和生物技术公司在研发领域投入巨资，其中核酸製备在生物标记发现、药物研发和临床试验中发挥着至关重要的作用。次世代定序（NGS）、液态生物检体和基因表现分析等技术的持续拓展应用，进一步推动了对能够高精度处理复杂生物样本的先进製备设备的需求。

此外，政府和私人部门对生命科学研究的投入增加，以及学术和研究机构的扩张，都在推动全球市场成长。在新兴国家，由于医疗基础设施的改善和人们对分子诊断意识的提高，分子诊断技术的应用也不断普及。磁珠萃取、微流体技术和人工智慧自动化等技术创新，正在提升这些设备的效能和易用性，使其更容易被广大终端使用者所接受。

市场概览

近年来，全球核酸样品製备设备市场经历了显着的变革，从传统的手工萃取技术发展成为高度自动化、高通量系统，而这些系统对于现代分子生物学工作流程至关重要。这些仪器在从各种生物样本中分离纯化DNA和RNA方面发挥关键作用，为聚合酵素链锁反应（PCR）、次世代定序（NGS）和基因表现分析等下游应用奠定了基础。

市场发展的主要驱动力是精准诊断需求的不断增长，尤其是在感染疾病检测、肿瘤学和基因检测等领域。随着个人化医疗和标靶治疗的推进，对可靠且高效的核酸製备技术的需求也日益凸显。因此，临床、科学研究和製药领域的实验室正越来越多地采用自动化解决方案，以提高准确性、可重复性和扩充性。

技术进步在塑造市场格局方面也发挥了至关重要的作用。磁珠萃取方法、微流体平台和整合式样品到结果係统等创新技术显着提高了工作流程效率，同时降低了污染风险并缩短了处理时间。此外，自动化和数位技术的融合实现了大批量样品的无缝处理，使这些仪器在高通量环境中不可或缺。

此外，基因组研究的拓展，以及各国政府和私人机构投入的资金增加，正加速全球先进​​核酸样本製备设备的应用。全球卫生危机期间的大规模检测经验，再次凸显了稳健且扩充性的样本製备解决方案的重要性，进一步推动了市场成长。总体而言，该市场正持续发展，成为诊断、生命科学研究和生物製药开发领域创新发展的关键驱动力。

对产业的影响

全球核酸样品製备设备市场正受到产业显着影响，这主要得益于先进样品製备技术在诊断、生命科学研究和生物製药生产等领域的日益普及。核酸萃取和纯化是分子工作流程的基础，促使各产业迅速采用自动化设备，以提高营运效率、确保数据准确性并满足大规模处理需求。这种转变使实验室和企业能够简化工作流程、缩短处理时间、最大限度地减少人为错误，并最终提高生产效率和成本效益。

在製药和生物技术领域，这些仪器对于药物发现、基因组研究和临床试验至关重要。精准医疗和标靶治疗的日益普及显着增加了对高品质核酸样本的需求，直接推动了先进样本製备系统的应用。此外，次世代定序（NGS）、液态生物检体和生物标记分析的日益广泛应用，进一步增强了对自动化和高通量解决方案的依赖，为仪器製造商开闢了新的成长途径。

诊断产业正经历重大变革，临床检查室越来越多地采用自动化核酸製备系统来处理大量检测样本并确保结果的一致性。这在传染病检查和肿瘤诊断领域尤其明显，因为快速可靠的检体处理至关重要。产业向一体化「检体到结果」平台的转型进一步提升了检查室能力，并推动了分散式检查模式的发展。

此外，核酸样本製备设备市场正在影响整个检查室自动化生态系统，推动机器人流体处理系统、微流体平台和人工智慧资料管理工具等配套技术的发展。製造商正致力于创新、策略合作和产品差异化，以满足不断变化的产业需求。因此，核酸样本製备设备市场不仅支持医学和研究的进步，而且推动整个生命科学价值链的自动化、扩充性和技术集成，从而重塑行业实践。

市场区隔:

细分 1：按产品类型

  • 核酸萃取系统
  • 样品破碎均质装置
  • 液体处理和自动化系统

预计核酸萃取系统细分市场将推动核酸样品製备设备市场（按产品类型划分）的发展。

按产品类型划分，核酸萃取系统预计将成为核酸样品製备设备市场的主要驱动力，因为它在分离下游分子应用所需的高品质DNA和RNA方面发挥着至关重要的作用。这些系统是PCR、次世代定序（NGS）和基因表现分析等工作流程中至关重要的第一步，并且已成为临床诊断、实验室、製药和生物技术产业不可或缺的工具。

该领域的领先地位主要源自于对自动化、高通量提取解决方案日益增长的需求，这些方案需确保准确性、可重复性和无污染处理。随着感染疾病、癌症和遗传性疾病的日益流行，实验室正优先采用能够处理包括血液、组织和唾液在内的多种样本类型的可靠萃取系统。此外，磁珠萃取和自动化纯化平台等技术的进步显着提高了效率并减少了人工干预，进一步加速了这些技术的应用。

此外，随着分子诊断和基因组学研究的拓展，对能够处理大量样本且不影响品质的高扩充性提取系统的需求日益增长。製药和生物技术公司也透过在药物研发、生物标记鑑定和临床试验中广泛应用这些系统，推动了该领域的成长。随着实验室朝向整合化和自动化工作流程发展，核酸萃取系统作为确保下游分析流程可靠性和成功率的关键因素，预计将继续保持其主导地位。

第二类细分：依技术

  • 自动化旋转柱系统
  • 磁珠以微珠为基础
  • 自动化液体处理

在核酸样品製备设备市场（按技术划分），磁珠法有望成为主导技术。

由于以微珠为基础技术具有卓越的效率、扩充性和与自动化工作流程的兼容性，预计将在核酸样品製备设备市场占据主导地位。此方法是核酸萃取和纯化的首选，因为它能够在包括血液、组织和复杂生物体液在内的多种样本类型中实现高产量和高纯度的DNA和RNA萃取。

分子诊断和基因组研究领域对高通量、无污染处理的需求日益增长，这是推动以微珠为基础应用的主要动力。与传统的柱式或手动萃取技术不同，磁珠技术能够实现无缝自动化，缩短处理时间，并最大限度地降低交叉污染的风险，使其成为临床检查室和大规模检测环境的理想选择。这在准确性和可重复性至关重要的应用中尤其重要，例如次世代定序(NGS)、PCR 和微量残存疾病(MRD) 检测。

此外，磁珠通讯协定的柔软性使其能够轻鬆整合到机器人液体处理系统和全自动平台中，从而进一步提高检查室效率。製药和生物技术公司正越来越多地将这项技术应用于药物发现、生物标记研究和临床试验，推动了其广泛应用。磁珠化学性质和自动化能力的不断进步，进一步提升了其性能并扩展了应用范围。

随着实验室不断优先考虑速度、精确性和扩充性，磁珠技术有望保持主导地位，这得益于其与持续向自动化和先进分子工作流程转变的紧密亲和性。

细分3：依处理能力划分

  • 低吞吐量设备
  • 中等通量设备
  • 高通量设备

在核酸样品製备设备市场（按处理能力划分），中等处理能力的设备预计将成为主流。

中等通量设备预计将凭藉其高通量优势，成为核酸样本製备设备市场的主要驱动力，因为它在处理能力、成本效益和操作柔软性之间实现了最佳平衡。这些系统尤其适用于中型实验室、诊断中心和研究机构，它们需要稳定的样本处理，但又不想像大规模高通量平台那样投入巨额资金。

此细分市场的优势源自于分子诊断领域对高效、扩充性解决方案日益增长的需求，尤其是在传染病检查、肿瘤诊断和基因分析等应用领域。中等通量仪器通常处理适中的样本量，因此非常适合日常实验室工作流程，因为在这些流程中，准确性、可重复性和周转时间至关重要。它们能够在不影响效能的前提下处理不同的样本负载量，因此成为各类终端使用者的首选。

此外，检查室自动化程度的不断提高也推动了对中等通量系统的需求。这些系统通常具有用户友好的介面和整合的通讯协定，并且兼容磁珠法等先进的提取技术。这些特性减少了人工干预，最大限度地降低了误差，并提高了检查室的整体效率。

製药和生物技术公司以及学术和研究机构正透过使用中等通量仪器进行药物发现、生物标记研究和临床试验检体处理等应用，推动这一领域的成长。随着实验室对能够适应不断变化的检测需求且经济高效、用途广泛的解决方案的需求持续增长，中等通量仪器有望继续保持主导地位。

细分 4：按最终用户

  • 学术研究机构
  • 製药和生物技术公司
  • 临床诊断中心
  • 应用测试（生物样本库、法医学和兽医研究所）
  • 受託研究机构

核酸样品製备设备市场（按最终用户划分）预计将由学术研究机构主导。

学术研究机构预计将成为核酸样品製备设备终端使用者市场的主要驱动力，这主要得益于它们在基因组研究、分子生物学研究和早期科学发现领域的广泛参与。这些机构是重要的创新中心，核酸萃取和纯化已成为基因表现分析、次世代定序(NGS) 和功能基因体学等众多应用领域不可或缺的关键步骤。

政府和私人机构对生命科学研究的大力投入是推动该领域发展的主要因素。大学和研究中心正不断增加对先进实验室基础设施的投资，包括自动化核酸样本製备设备，以提高研究效率并确保获得高品质、可重复的结果。此外，对癌症研究、感染疾病和遗传疾病等领域的日益关注，也扩大了学术机构对可靠样本製备技术的需求。

学术机构在大规模合作计划和联盟研究中发挥着至关重要的作用，这些计画和研究通常需要处理大量的生物样本。这促使人们采用能够处理各种复杂工作流程的中高通量仪器。此外，学术机构与製药和生物技术公司之间的合作有助于技术转移，并加速先进核酸製备解决方案的应用。

随着基因组学的不断进步和精准医疗的日益普及，学术研究机构预计仍将是主要的终端使用者群体。它们持续的研究活动、创新以及对尖端实验室技术的需求将显着推动市场成长。

细分5：按地区

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 波兰
    • 葡萄牙
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 马来西亚
    • 韩国
    • 泰国
    • 台湾
    • 新加坡
    • 印尼
    • 菲律宾
    • 亚太其他地区
  • 拉丁美洲
    • 阿根廷
    • 巴西
    • 智利
    • 墨西哥
    • 哥伦比亚
    • 其他拉丁美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他中东和非洲地区

从区域来看，北美在核酸样品製备设备市场处于领先地位。

从区域来看，北美预计将成为核酸样本製备设备市场的主要驱动力。这主要得益于其完善的医疗保健基础设施、许多大型生物技术和製药公司的强大影响力，以及先进分子诊断技术的高度普及。该地区，尤其是美国，是全球基因组研究和精准医疗的中心，极大地推动了对高效自动化核酸製备系统的需求。

该地区占据主导地位的主要因素是政府机构和私营组织对研发的大量投入。来自美国国立卫生研究院 (NIH) 等机构的资助，以及业内企业的持续创新，正在加速先进实验室自动化解决方案的普及应用。此外，慢性病、癌症和感染疾病的日益流行，进一步增加了对可靠分子检测的需求，从而推动了对核酸样本製备设备的需求。

北美地区也受惠于早期采用的最尖端科技，例如次世代定序(NGS)、基于 PCR 的诊断方法和自动化流体处理系统。主要市场参与者的存在、频繁的产品发布、合作研究和战略伙伴关係进一步巩固了该地区的领先地位。此外，随着人们的关注点转向个人化医疗和基于生物标记的疗法，对高品质核酸萃取和纯化过程的依赖性也日益增强。

此外，该地区强大的临床和研究生态系统，包括学术机构、诊断检查室和生物製药公司，确保了对这些设备的持续需求。有利的法规结构以及对品质和标准化的高度重视也促进了这些设备的广泛应用。因此，预计北美将在整个预测期内保持其在全球核酸样本製备设备市场的主导地位。

核酸样品製备设备市场最新趋势

  • 2025年10月，AutoGen公司与Sampled公司合作，开始提供新一代核酸萃取和多组体学工作流程。根据该协议，Sampled公司将把复杂的提取计划转介给AutoGen公司，而AutoGen公司将把大规模提取和下游分析委託给Sampled公司的一体化化验服务。
  • 2025 年 4 月，QIAGEN NV 宣布计画在 2025 年至 2026 年间推出三款新的样品製备系统（QIAsymphony Connect、QIAsprint 和 QIAmini），以提高实验室各环节的自动化程度和效率。

需求——驱动因素、挑战与机会

市场驱动因素：

分子诊断和基因组检测需求的不断增长正在推动核酸样本製备设备市场的发展。为了满足日益增长的分子检测需求，公共卫生机构和临床检查室正优先采用自动化且可重复的样本製备平台。随着检测数量的持续增加，专注于提高提取效率、处理能力以及与下游工作流程整合度的设备製造商将更有利于扩大市场份额。

市场挑战

高成本－成本障碍不仅是价格问题，更是影响公共和私人医疗系统采购决策的市场准入挑战。为了扩大核酸样本製备技术的应用，设备製造商可能需要开发创新的定价策略、模组化系统方案或资金筹措合作模式，特别要关注公共卫生检查室和中低收入地区。解决设备价格可负担性问题能够刺激潜在需求，从而加速分子检测基础设施的现代化，并促进全球更公平地获取先进诊断技术。

市场机会

自动化和整合工作流程—核酸样品製备仪器製造商需要不断创新并整合工作流程，以扩大仪器的应用范围，尤其是在高通量、临床和实验室环境中。随着分子诊断需求的持续增长，能够提供无缝、可重复且可扩展的样品製备工作流程的平台，将透过解决週转时间、品管和营运成本效益等关键检查室挑战而脱颖而出。

这份报告将为贵公司带来哪些附加价值？

产品与创新策略－全球核酸样本製备设备市场细分为多个关键部分，包括产品类型、技术、处理能力、终端使用者和区域市场。透过了解哪些细分市场占据最大的市场份额以及哪些细分市场具有成长潜力，本报告为旨在创新产品和扩展产品组合的企业提供了宝贵的见解。

成长与行销策略：策略伙伴关係、伙伴关係和业务扩张预计将在核酸样本製备设备市场的成长中发挥核心作用。诊断公司、医疗服务提供者和研究机构之间的关键发展和合作已经开始成为市场动态的重要组成部分。

竞争策略：核酸样品製备设备市场竞争异常激烈，Thermo Fisher Scientific Inc.、QIAGEN NV、F. Hoffmann-La Roche AG、Danaher Corporation 和 Agilent Technologies, Inc. 等主要企业凭藉强大的产品系列和持续创新引领市场。各公司均致力于自动化、先进的提取技术和策略联盟，以提高效率并扩大市场影响，从而创造出充满活力且创新主导的市场环境。

调查方法

市场设计与检验的关键考量与假设

  • 对于全球市场规模估算，涵盖的期间为 2024 年至 2035 年，其中 2024 年为基准年，2025 年至 2035 年为预测期。
  • 本报告的范围是基于来自各行业的专家提供的全面信息，包括专科诊所、医院、诊断检查室、参考检查室和研究机构。
  • 核酸样品製备设备的市场份额预计未来将大幅增长，这一预测是基于对现有解决方案历史数据的分析得出的。
  • 每家公司的企业获利均根据其2024年年度报告计算。对于私人公司，企业获利估算则来自一手调查数据、资金筹措历史、市场合作关係和业务表现。
  • 本报告基于现有的核酸样本製备设备、市场产品和服务，对市场进行了分析。报告还识别并介绍了该领域提供关键产品和服务的主要企业。

主要市场参与企业及竞争格局概述

本报告中介绍的公司简介是根据对每家公司的业务范围、产品系列和市场渗透率的分析而选择的。

该市场的主要企业包括以下几家：

  • F. Hoffmann-La Roche AG
  • Promega Corporation
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
  • Tecan Trading AG
  • Eppendorf
  • Macherey-Nagel GmbH & Co. KG
  • Sage Science, Inc.
  • Hamilton Company
  • Revvity, Inc. (PerkinElmer, Inc.)
  • AutoGen Inc.
  • Hain Lifescience GmbH / BRUKER
  • bioMerieux, Inc.
  • Aurora Biomed Inc.
  • Genetic Signatures
  • Bioteke Corporation

目录

执行摘要

第一章 市场：产业展望

  • 市场概览与生态系统
  • 市场吸引力：宏观与微观因素分析
  • 监理展望
  • 价格分析

第二章：全球核酸样品製备设备市场概览

  • 商业动态
    • 影响分析
    • 市场驱动因素
    • 市场限制因素
    • 市场机会与趋势

第三章：2024-2035年全球核酸样品製备设备市场（依产品类型划分）

  • 概述
  • 成长占有率矩阵
  • 核酸萃取系统
  • 样品破碎均质装置
  • 液体处理和自动化系统

第四章：2024-2035年全球核酸样品製备设备市场（依技术划分）

  • 概述
  • 成长占有率矩阵
  • 自动旋转柱底座
  • 利用磁珠提高磁通量
  • 自动化液体处理

第五章：2024-2035年全球核酸样品製备设备市场（依吞吐量划分）

  • 概述
  • 成长占有率矩阵
  • 低吞吐量设备
  • 中等通量设备
  • 高通量设备

第六章：2024-2035年全球核酸样品製备设备市场（依最终使用者划分）

  • 概述
  • 成长占有率矩阵
  • 学术研究机构
  • 製药和生物技术公司
  • 临床诊断中心
  • 应用检测（生物样本库、法医学研究所、兽医研究所）
  • 受託研究机构

第七章 区域

  • 区域概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第八章 市场－竞争标竿分析与公司概况

  • 产品基准测试
  • 关键策略和企业发展（按公司划分）
  • 企业市场占有率分析
  • 公司简介
    • F. Hoffmann-La Roche AG
    • Promega Corporation
    • QIAGEN NV
    • Thermo Fisher Scientific Inc.
    • Tecan Trading AG
    • Eppendorf
    • Macherey-Nagel GmbH & Co. KG
    • Sage Science, Inc.
    • Hamilton Company
    • Revvity, Inc. (PerkinElmer, Inc.)
    • AutoGen Inc.
    • Hain Lifescience GmbH/BRUKER
    • bioMerieux, Inc
    • Aurora Biomed Inc.
    • Genetic Signatures
    • Bioteke Corporation

第九章：调查方法

Product Code: BHL3509SA

This report can be delivered within 1 working day.

Introduction of the Nucleic Acid Sample Preparation Instruments Market

The global nucleic acid sample preparation instruments market, initially valued at $910.1 million in 2024, is projected to witness substantial growth, surging to $1,601.8 million by 2035, marking a remarkable compound annual growth rate (CAGR) of 5.10% over the period from 2025 to 2035.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$974.3 Million
2035 Forecast$1,601.8 Million
CAGR5.1%

The market is experiencing sustained expansion, driven by the increasing demand for accurate and rapid molecular diagnostics, particularly in the detection of infectious diseases, oncology biomarkers, and genetic disorders. The growing burden of conditions such as cancer, viral infections, and rare genetic diseases has significantly accelerated the need for efficient nucleic acid extraction and purification systems, which form the foundation of downstream applications like PCR and next-generation sequencing (NGS).

A key growth driver is the rising adoption of automated and high-throughput nucleic acid sample preparation instruments, which enhance laboratory efficiency by minimizing manual intervention, reducing human error, and ensuring reproducibility of results. Laboratories are increasingly transitioning toward fully integrated workflows that combine extraction, purification, and analysis, thereby improving turnaround times and enabling large-scale testing, especially in clinical and diagnostic settings. This trend has been further reinforced by the lessons learned during the COVID-19 pandemic, which highlighted the critical importance of scalable and reliable sample preparation technologies.

Moreover, the rapid advancements in genomics and personalized medicine are contributing significantly to market growth. Pharmaceutical and biotechnology companies are investing heavily in research and development activities, where nucleic acid preparation plays a crucial role in biomarker discovery, drug development, and clinical trials. The expanding applications of NGS, liquid biopsy, and gene expression analysis are further boosting demand for advanced preparation instruments capable of handling complex biological samples with high precision.

In addition, increasing government funding and private investments in life sciences research, along with the expansion of academic and research institutes, are supporting market growth globally. Emerging economies are also witnessing rising adoption due to improving healthcare infrastructure and growing awareness of molecular diagnostics. Technological innovations, such as magnetic bead-based extraction, microfluidics, and AI-enabled automation, are enhancing the performance and usability of these instruments, making them more accessible across diverse end users.

Market Introduction

The global nucleic acid sample preparation instruments market has undergone a significant transformation in recent years, evolving from conventional manual extraction techniques to highly automated, high-throughput systems that are integral to modern molecular biology workflows. These instruments play a critical role in the isolation and purification of DNA and RNA from a wide range of biological samples, forming the foundation for downstream applications such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and gene expression analysis.

The market's evolution has been largely driven by the growing demand for precision diagnostics, particularly in areas such as infectious disease detection, oncology, and genetic testing. The increasing shift toward personalized medicine and targeted therapies has further emphasized the need for reliable and efficient nucleic acid preparation technologies. As a result, laboratories across clinical, research, and pharmaceutical settings are increasingly adopting automated solutions that offer improved accuracy, reproducibility, and scalability.

Technological advancements have also played a pivotal role in shaping the market landscape. Innovations such as magnetic bead-based extraction methods, microfluidic platforms, and integrated sample-to-result systems have significantly enhanced workflow efficiency while reducing contamination risks and processing time. Additionally, the integration of automation and digital technologies has enabled seamless handling of large sample volumes, making these instruments indispensable in high-throughput environments.

Furthermore, the expansion of genomics research, coupled with increased funding from governments and private organizations, has accelerated the adoption of advanced nucleic acid sample preparation instruments globally. The experience of large-scale testing during global health crises has reinforced the importance of robust and scalable sample preparation solutions, further driving market growth. Overall, the market continues to advance as a key enabler of innovation in diagnostics, life sciences research, and biopharmaceutical development.

Industrial Impact

The global nucleic acid sample preparation instruments market has witnessed a substantial industrial impact, driven by the increasing integration of advanced sample preparation technologies across diagnostics, life sciences research, and biopharmaceutical manufacturing. As nucleic acid extraction and purification form the backbone of molecular workflows, industries are rapidly adopting automated instruments to enhance operational efficiency, ensure data accuracy, and support large-scale processing requirements. This shift is enabling laboratories and companies to streamline workflows, reduce turnaround times, and minimize manual errors, ultimately improving productivity and cost-effectiveness.

In the pharmaceutical and biotechnology sectors, these instruments have become indispensable for drug discovery, genomic research, and clinical trials. The rising focus on precision medicine and targeted therapies has significantly increased the demand for high-quality nucleic acid samples, directly impacting the adoption of advanced preparation systems. Additionally, the growing use of next-generation sequencing (NGS), liquid biopsy, and biomarker analysis has further strengthened the reliance on automated and high-throughput solutions, creating new growth avenues for instrument manufacturers.

The diagnostics industry has also experienced a notable transformation, as clinical laboratories increasingly incorporate automated nucleic acid preparation systems to manage high testing volumes and maintain consistent results. This has been particularly evident in infectious disease testing and oncology diagnostics, where rapid and reliable sample processing is critical. The industrial shift toward integrated, sample-to-result platforms is further enhancing laboratory capabilities and enabling decentralized testing models.

Moreover, the market is influencing the broader laboratory automation ecosystem, encouraging the development of complementary technologies such as robotic liquid handling systems, microfluidic platforms, and AI-driven data management tools. Manufacturers are focusing on innovation, strategic collaborations, and product differentiation to meet evolving industry needs. As a result, the nucleic acid sample preparation instruments market is not only supporting advancements in healthcare and research but also reshaping industrial practices by promoting automation, scalability, and technological integration across the life sciences value chain.

Market Segmentation:

Segmentation 1: By Product Type

  • Nucleic Acid Extraction Systems
  • Sample Disruption and Homogenization Instruments
  • Liquid Handling and Automation Systems

Nucleic Acid Extraction Systems Segment to Dominate the Nucleic Acid Sample Preparation Instruments Market (by Product Type)

The nucleic acid extraction systems segment is expected to dominate the nucleic acid sample preparation instruments market by product type, owing to its fundamental role in isolating high-quality DNA and RNA required for downstream molecular applications. These systems represent the first and most critical step in workflows such as PCR, next-generation sequencing (NGS), and gene expression analysis, making them indispensable across clinical diagnostics, research laboratories, and pharmaceutical and biotechnology industries.

The dominance of this segment is largely driven by the increasing demand for automated and high-throughput extraction solutions that ensure accuracy, reproducibility, and contamination-free processing. With the rising prevalence of infectious diseases, cancer, and genetic disorders, laboratories are prioritizing reliable extraction systems capable of handling diverse sample types, including blood, tissue, and saliva. Additionally, advancements in technologies such as magnetic bead-based extraction and automated purification platforms have significantly improved efficiency and reduced manual intervention, further boosting adoption.

Moreover, the expansion of molecular diagnostics and genomics research has amplified the need for scalable extraction systems that can support large sample volumes without compromising quality. Pharmaceutical and biotechnology companies are also contributing to segment growth through extensive use of these systems in drug discovery, biomarker identification, and clinical trials. As laboratories continue to transition toward integrated and automated workflows, nucleic acid extraction systems are expected to maintain their leading position, driven by their critical importance in ensuring the reliability and success of downstream analytical processes.

Segmentation 2: By Technology

  • Automated Spin-Column based
  • Magnetic Bead-Based
  • Automated Liquid Handling

Magnetic Bead-Based to Dominate the Nucleic Acid Sample Preparation Instruments Market (by Technology)

Magnetic bead-based technology is expected to dominate the nucleic acid sample preparation instruments market by technology, owing to its superior efficiency, scalability, and compatibility with automated workflows. This method has become the preferred choice for nucleic acid extraction and purification due to its ability to deliver high yield and purity of DNA and RNA across a wide range of sample types, including blood, tissue, and complex biological fluids.

The growing demand for high-throughput and contamination-free processing in molecular diagnostics and genomics research is a key factor driving the adoption of magnetic bead-based systems. Unlike traditional column-based or manual extraction techniques, magnetic bead technology enables seamless automation, reduces hands-on time, and minimizes the risk of cross-contamination, making it highly suitable for clinical laboratories and large-scale testing environments. This is particularly important in applications such as next-generation sequencing (NGS), PCR, and minimal residual disease (MRD) testing, where precision and reproducibility are critical.

Additionally, the flexibility of magnetic bead-based protocols allows for easy integration into robotic liquid handling systems and fully automated platforms, further enhancing laboratory efficiency. Pharmaceutical and biotechnology companies are increasingly utilizing this technology in drug discovery, biomarker research, and clinical trials, contributing to its widespread adoption. Continuous advancements in bead chemistry and automation capabilities are further improving performance and expanding application areas.

As laboratories continue to prioritize speed, accuracy, and scalability, magnetic bead-based technology is expected to maintain its leading position in the market, supported by its strong alignment with the ongoing shift toward automation and advanced molecular workflows.

Segmentation 3: By Throughput

  • Low-Throughput Instruments
  • Medium-Throughput Instruments
  • High-Throughput Instruments

Medium-Throughput Instruments to Dominate the Nucleic Acid Sample Preparation Instruments Market (by Throughput)

Medium-throughput instruments are expected to dominate the nucleic acid sample preparation instruments market by throughput, as they offer an optimal balance among processing capacity, cost-efficiency, and operational flexibility. These systems are particularly well-suited for mid-sized laboratories, diagnostic centers, and research facilities that require consistent sample processing without the high capital investment associated with large-scale, high-throughput platforms.

The dominance of this segment is driven by the growing demand for efficient yet scalable solutions in molecular diagnostics, especially for applications such as infectious disease testing, oncology diagnostics, and genetic analysis. Medium throughput instruments typically support moderate sample volumes, making them ideal for routine laboratory workflows where accuracy, reproducibility, and turnaround time are critical. Their ability to handle varying sample loads without compromising performance makes them a preferred choice across diverse end users.

Additionally, the increasing adoption of automation in laboratories is boosting demand for medium-throughput systems, as they often come equipped with user-friendly interfaces, integrated protocols, and compatibility with advanced extraction technologies such as magnetic bead-based methods. These features help reduce manual intervention, minimize errors, and improve overall laboratory productivity.

Pharmaceutical and biotechnology companies, along with academic and research institutes, are also contributing to the growth of this segment by utilizing medium-throughput instruments for applications such as drug discovery, biomarker research, and clinical trial sample processing. As laboratories continue to seek cost-effective and versatile solutions that adapt to evolving testing needs, medium-throughput instruments are expected to maintain their leading position in the market.

Segmentation 4: By End User

  • Academic Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Clinical Diagnostic Centers
  • Applied Testing (Biobanks, Forensic and Veterinary Laboratories)
  • Contract Research Organizations

Academic Research Institutes to Dominate the Nucleic Acid Sample Preparation Instruments Market (by End User)

Academic research institutes are expected to dominate the nucleic acid sample preparation instruments market by end user, driven by their extensive involvement in genomics research, molecular biology studies, and early-stage scientific discovery. These institutions serve as key hubs for innovation, where nucleic acid extraction and purification are fundamental to a wide range of applications, including gene expression analysis, next-generation sequencing (NGS), and functional genomics.

The strong presence of government and private funding for life sciences research has significantly contributed to the growth of this segment. Universities and research centers are increasingly investing in advanced laboratory infrastructure, including automated nucleic acid sample preparation instruments, to enhance research efficiency and ensure high-quality, reproducible results. Additionally, the growing focus on areas such as cancer research, infectious diseases, and genetic disorders has amplified the demand for reliable sample preparation technologies within academic settings.

Academic institutes also play a crucial role in large-scale collaborative projects and consortium-based research, which often require processing high volumes of biological samples. This drives the adoption of both medium- and high-throughput instruments capable of supporting diverse and complex workflows. Furthermore, partnerships between academic institutions and pharmaceutical or biotechnology companies are fostering technology transfer and accelerating the adoption of advanced nucleic acid preparation solutions.

With continuous advancements in genomics and increasing emphasis on precision medicine, academic research institutes are expected to remain a dominant end-user segment, contributing significantly to market growth through sustained research activities, innovation, and demand for cutting-edge laboratory technologies.

Segmentation 5: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Netherlands
    • Poland
    • Portugal
    • Russia
    • Rest-of-Europe
  • Asia-Pacific
    • Australia
    • China
    • India
    • Japan
    • Malaysia
    • South Korea
    • Thailand
    • Taiwan
    • Singapore
    • Indonesia
    • Philippines
    • Rest-of-Asia-Pacific
  • Latin America
    • Argentina
    • Brazil
    • Chile
    • Mexico
    • Colombia
    • Rest-of-Latin America
  • Middle East and Africa
    • KSA
    • U.A.E.
    • South Africa
    • Rest-of-Middle East and Africa

North America to Dominate the Nucleic Acid Sample Preparation Instruments Market (by Region)

North America is expected to dominate the nucleic acid sample preparation instruments market by region, driven by its well-established healthcare infrastructure, strong presence of leading biotechnology and pharmaceutical companies, and high adoption of advanced molecular diagnostic technologies. The region, particularly the United States, serves as a global hub for genomics research and precision medicine, significantly contributing to the demand for efficient and automated nucleic acid preparation systems.

A key factor supporting regional dominance is the substantial investment in research and development activities by both government bodies and private organizations. Funding from agencies such as the National Institutes of Health (NIH), along with continuous innovation by industry players, has accelerated the adoption of advanced laboratory automation solutions. Additionally, the increasing prevalence of chronic diseases, cancer, and infectious diseases has further boosted the need for reliable molecular testing, thereby driving demand for nucleic acid sample preparation instruments.

North America also benefits from the early adoption of cutting-edge technologies, including next-generation sequencing (NGS), PCR-based diagnostics, and automated liquid handling systems. The presence of major market players and frequent product launches, collaborations, and strategic partnerships further strengthens the region's leadership position. Moreover, the growing focus on personalized medicine and biomarker-based therapies is increasing the reliance on high-quality nucleic acid extraction and purification processes.

Furthermore, the region's robust clinical and research ecosystem, comprising academic institutions, diagnostic laboratories, and biopharmaceutical companies, ensures sustained demand for these instruments. Favorable regulatory frameworks and a strong emphasis on quality and standardization also contribute to widespread adoption. As a result, North America is expected to maintain its dominance in the global nucleic acid sample preparation instruments market over the forecast period.

Recent Developments in the Nucleic Acid Sample Preparation Instruments Market

  • In October 2025, AutoGen, Inc. partnered with Sampled to deliver next-generation nucleic acid extraction and multi-omic workflows. Under the agreement, Sampled refers complex extraction projects to AutoGen; AutoGen refers large-scale extraction and downstream analysis to Sampled's integrated laboratory services.
  • In April 2025, QIAGEN N.V. announced plans to launch three new sample preparation instruments (QIAsymphony Connect, QIAsprint, QIAmini) in 2025-2026 to improve automation and efficiency across lab segments.

Demand - Drivers, Challenges, and Opportunities

Market Drivers:

Rising Demand for Molecular Diagnostics and Genomic Testing: This market for nucleic acid sample preparation instruments is driven by the shift toward molecular testing. To meet the growing demand for molecular testing, public health and clinical laboratories are giving priority to acquiring automated and repeatable preparation platforms. As testing volumes continue to rise, instrument makers who concentrate on innovation in extraction efficiency, throughput, and integration with downstream workflows are well-positioned to gain a larger portion of the market.

Market Challenges:

High Cost of Instruments: The cost barrier is not merely a pricing issue but a market access challenge that influences purchasing decisions across public and private health systems. To broaden the uptake of nucleic acid sample preparation technologies, instrument manufacturers may need to develop innovative price strategies, modular system alternatives, or finance collaborations, especially for public health laboratories and low and middle-income regions. Latent demand could be unlocked by addressing affordability, the infrastructure for molecular testing could be modernised more quickly, and more equitable access to advanced diagnostics could be supported globally.

Market Opportunities:

Automation and Integrated Workflows: nucleic acid sample preparation instrument manufacturers would need to continue innovation and workflow integration to increase instrument adoption, especially in high-throughput, clinical, and research settings. As demand for molecular diagnostics continues to grow, platforms that deliver seamless, reproducible, and scalable preparation workflows will differentiate themselves by addressing critical laboratory challenges such as turnaround time, quality control, and operational cost efficiency.

How can this report add value to an organization?

Product/Innovation Strategy: The global nucleic acid sample preparation instruments market has been divided into several key segments, including product type, technology, Throughput, end users, and regional markets. By understanding which segments hold the largest share and which ones show potential for growth, this report offers invaluable insights for organizations looking to innovate and expand their product offerings.

Growth/Marketing Strategy: Strategic partnerships, collaborations, and business expansions are anticipated to be central to the growth of the nucleic acid sample preparation instruments market. Key developments and partnerships among diagnostic companies, healthcare providers, and research institutions have already begun to form a significant part of the market dynamics.

Competitive Strategy: The nucleic acid sample preparation instruments Market is highly competitive, with key players such as Thermo Fisher Scientific Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Danaher Corporation, and Agilent Technologies, Inc. leading through strong product portfolios and continuous innovation. Companies are focusing on automation, advanced extraction technologies, and strategic collaborations to enhance efficiency and expand their market presence, making the landscape dynamic and innovation-driven.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • Years from 2024 to 2035 have been considered for the global market size estimation, 2024 has been considered as the base year, and 2025 to 2035 as the forecast period.
  • The scope of the report is based on comprehensive inputs from industry experts across various sectors, including specialty clinics and hospitals, diagnostic laboratories, reference laboratories, and research institutions.
  • The market contribution of nucleic acid sample preparation instruments is anticipated to grow substantially in the future, with projections based on historical analysis of available solutions.
  • Revenues from companies have been sourced from their annual reports for FY2024. For private companies, revenue estimates are derived from primary research inputs, funding history, market collaborations, and operational performance.
  • The market has been mapped based on the existing nucleic acid sample preparation instruments, market products, and services. Key companies with significant offerings in this field have been identified and profiled in this report.

Primary Research

The primary sources involve industry experts in the nucleic acid sample preparation instruments market, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of report segmentations and key qualitative findings
  • understanding the competitive landscape and business model
  • current and proposed production values of a product by market players
  • validation of the numbers of different segments of the market in focus
  • percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investors' presentations of the leading market players
  • Company websites and a detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players in the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • F. Hoffmann-La Roche AG
  • Promega Corporation
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Tecan Trading AG
  • Eppendorf
  • Macherey-Nagel GmbH & Co. KG
  • Sage Science, Inc.
  • Hamilton Company
  • Revvity, Inc. (PerkinElmer, Inc.)
  • AutoGen Inc.
  • Hain Lifescience GmbH / BRUKER
  • bioMerieux, Inc.
  • Aurora Biomed Inc.
  • Genetic Signatures
  • Bioteke Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Market Overview and Ecosystem
  • 1.2 Market Attractiveness: Macro and Micro Factor Analysis
  • 1.3 Regulatory Outlook
  • 1.4 Pricing Analysis

2 Global Nucleic Acid Sample Preparation Instruments Market Overview

  • 2.1 Business Dynamics
    • 2.1.1 Impact Analysis
    • 2.1.2 Market Drivers
      • 2.1.2.1 Rising Demand for Molecular Diagnostics and Genomic Testing
      • 2.1.2.2 High Prevalence of Infectious Diseases and Chronic Conditions
      • 2.1.2.3 Growth in Genomic Research and Personalized Medicine
    • 2.1.3 Market Restraints
      • 2.1.3.1 High Cost of Instruments
      • 2.1.3.2 Technical Complexity and Standardization
    • 2.1.4 Market Opportunities and Trends
      • 2.1.4.1 Opportunities
        • 2.1.4.1.1 Automation and Integrated Workflows
        • 2.1.4.1.2 Growth in Emerging Markets
      • 2.1.4.2 Trends
        • 2.1.4.2.1 Shift toward Magnetic Bead-Based Technology
        • 2.1.4.2.2 Higher Throughput Demand in Clinical Labs

3 Global Nucleic Acid Sample Preparation Instruments Market, 2024-2035, by Product Type

  • 3.1 Overview
  • 3.2 Growth-Share Matrix
  • 3.3 Nucleic Acid Extraction Systems
  • 3.4 Sample Disruption and Homogenization Instruments
  • 3.5 Liquid Handling and Automation Systems

4 Global Nucleic Acid Sample Preparation Instruments Market, 2024-2035, by Technology

  • 4.1 Overview
  • 4.2 Growth-Share Matrix
  • 4.3 Automated Spin-Column based
  • 4.4 Magnetic Bead Based Throughput
  • 4.5 Automated Liquid Handling

5 Global Nucleic Acid Sample Preparation Instruments Market, 2024-2035, by Throughput

  • 5.1 Overview
  • 5.2 Growth-Share Matrix
  • 5.3 Low-Throughput Instruments
  • 5.4 Medium-Throughput Instruments
  • 5.5 High-Throughput Instruments

6 Global Nucleic Acid Sample Preparation Instruments Market, 2024-2035, by End User

  • 6.1 Overview
  • 6.2 Growth-Share Matrix
  • 6.3 Academic Research Institute
  • 6.4 Pharmaceutical and Biotechnology Companies
  • 6.5 Clinical Diagnostic Centers
  • 6.6 Applied Testing (Biobanks, Forensic and Veterinary Laboratories)
  • 6.7 Contract Research Organizations

7 Region

  • 7.1 Regional Summary
  • 7.2 North America
    • 7.2.1 Regional Overview
    • 7.2.2 Driving Factors for Market Growth
    • 7.2.3 Factors Challenging the Market
    • 7.2.4 By Country
      • 7.2.4.1 U.S.
      • 7.2.4.2 Canada
  • 7.3 Europe
    • 7.3.1 Regional Overview
    • 7.3.2 Driving Factors for Market Growth
    • 7.3.3 Factors Challenging the Market
    • 7.3.4 By Country
      • 7.3.4.1 Germany
      • 7.3.4.2 U.K.
      • 7.3.4.3 France
      • 7.3.4.4 Italy
      • 7.3.4.5 Spain
      • 7.3.4.6 Netherlands
      • 7.3.4.7 Poland
      • 7.3.4.8 Portugal
      • 7.3.4.9 Russia
      • 7.3.4.10 Rest-of-Europe
  • 7.4 Asia Pacific
    • 7.4.1 Regional Overview
    • 7.4.2 Driving Factors for Market Growth
    • 7.4.3 Factors Challenging the Market
    • 7.4.4 By Country
      • 7.4.4.1 Australia
      • 7.4.4.2 China
      • 7.4.4.3 India
      • 7.4.4.4 Japan
      • 7.4.4.5 Malaysia
      • 7.4.4.6 South Korea
      • 7.4.4.7 Thailand
      • 7.4.4.8 Taiwan
      • 7.4.4.9 Singapore
      • 7.4.4.10 Indonesia
      • 7.4.4.11 Philippines
      • 7.4.4.12 Rest-of-Asia-Pacific
  • 7.5 Latin America
    • 7.5.1 Regional Overview
    • 7.5.2 Driving Factors for Market Growth
    • 7.5.3 Factors Challenging the Market
    • 7.5.4 By Country
      • 7.5.4.1 Argentina
      • 7.5.4.2 Brazil
      • 7.5.4.3 Chile
      • 7.5.4.4 Mexico
      • 7.5.4.5 Colombia
      • 7.5.4.6 Rest-of-Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 Regional Overview
    • 7.6.2 Driving Factors for Market Growth
    • 7.6.3 Factors Challenging the Market
    • 7.6.4 By Country
      • 7.6.4.1 Saudi Arabia
      • 7.6.4.2 South Africa
      • 7.6.4.3 U.A.E.
      • 7.6.4.4 Rest of the Middle East and Africa

8 Markets - Competitive Benchmarking & Company Profiles

  • 8.1 Product Benchmarking
  • 8.2 Key Strategies and Developments (by Company)
    • 8.2.1 Partnerships, Collaborations, and Business Expansions
    • 8.2.2 New Offerings
  • 8.3 Company Share Analysis
  • 8.4 Company Profiles
    • 8.4.1 F. Hoffmann-La Roche AG
      • 8.4.1.1 Overview
      • 8.4.1.2 Top Products/Product Portfolio
      • 8.4.1.3 Top Competitors
      • 8.4.1.4 Target Customers
      • 8.4.1.5 Key Personal
      • 8.4.1.6 Analyst View
    • 8.4.2 Promega Corporation
      • 8.4.2.1 Overview
      • 8.4.2.2 Top Products/Product Portfolio
      • 8.4.2.3 Top Competitors
      • 8.4.2.4 Target Customers
      • 8.4.2.5 Key Personal
      • 8.4.2.6 Analyst View
    • 8.4.3 QIAGEN N.V.
      • 8.4.3.1 Overview
      • 8.4.3.2 Top Products/Product Portfolio
      • 8.4.3.3 Top Competitors
      • 8.4.3.4 Target Customers
      • 8.4.3.5 Key Personal
      • 8.4.3.6 Analyst View
    • 8.4.4 Thermo Fisher Scientific Inc.
      • 8.4.4.1 Overview
      • 8.4.4.2 Top Products/Product Portfolio
      • 8.4.4.3 Top Competitors
      • 8.4.4.4 Target Customers
      • 8.4.4.5 Key Personal
      • 8.4.4.6 Analyst View
    • 8.4.5 Tecan Trading AG
      • 8.4.5.1 Overview
      • 8.4.5.2 Top Products/Product Portfolio
      • 8.4.5.3 Top Competitors
      • 8.4.5.4 Target Customers
      • 8.4.5.5 Key Personal
      • 8.4.5.6 Analyst View
    • 8.4.6 Eppendorf
      • 8.4.6.1 Overview
      • 8.4.6.2 Top Products/Product Portfolio
      • 8.4.6.3 Top Competitors
      • 8.4.6.4 Target Customers
      • 8.4.6.5 Key Personal
      • 8.4.6.6 Analyst View
    • 8.4.7 Macherey-Nagel GmbH & Co. KG
      • 8.4.7.1 Overview
      • 8.4.7.2 Top Products/Product Portfolio
      • 8.4.7.3 Top Competitors
      • 8.4.7.4 Target Customers
      • 8.4.7.5 Key Personal
      • 8.4.7.6 Analyst View
    • 8.4.8 Sage Science, Inc.
      • 8.4.8.1 Overview
      • 8.4.8.2 Top Products/Product Portfolio
      • 8.4.8.3 Top Competitors
      • 8.4.8.4 Target Customers
      • 8.4.8.5 Key Personal
      • 8.4.8.6 Analyst View
    • 8.4.9 Hamilton Company
      • 8.4.9.1 Overview
      • 8.4.9.2 Top Products/Product Portfolio
      • 8.4.9.3 Top Competitors
      • 8.4.9.4 Target Customers
      • 8.4.9.5 Key Personal
      • 8.4.9.6 Analyst View
    • 8.4.10 Revvity, Inc. (PerkinElmer, Inc.)
      • 8.4.10.1 Overview
      • 8.4.10.2 Top Products/Product Portfolio
      • 8.4.10.3 Top Competitors
      • 8.4.10.4 Target Customers
      • 8.4.10.5 Key Personal
      • 8.4.10.6 Analyst View
    • 8.4.11 AutoGen Inc.
      • 8.4.11.1 Overview
      • 8.4.11.2 Top Products/Product Portfolio
      • 8.4.11.3 Top Competitors
      • 8.4.11.4 Target Customers
      • 8.4.11.5 Key Personal
      • 8.4.11.6 Analyst View
    • 8.4.12 Hain Lifescience GmbH/BRUKER
      • 8.4.12.1 Overview
      • 8.4.12.2 Top Products/Product Portfolio
      • 8.4.12.3 Top Competitors
      • 8.4.12.4 Target Customers
      • 8.4.12.5 Key Personal
      • 8.4.12.6 Analyst View
    • 8.4.13 bioMerieux, Inc
      • 8.4.13.1 Overview
      • 8.4.13.2 Top Products/Product Portfolio
      • 8.4.13.3 Top Competitors
      • 8.4.13.4 Target Customers
      • 8.4.13.5 Key Personnel
      • 8.4.13.6 Analyst View
    • 8.4.14 Aurora Biomed Inc.
      • 8.4.14.1 Overview
      • 8.4.14.2 Top Products/Product Portfolio
      • 8.4.14.3 Top Competitors
      • 8.4.14.4 Target Customers
      • 8.4.14.5 Key Personnel
      • 8.4.14.6 Analyst View
    • 8.4.15 Genetic Signatures
      • 8.4.15.1 Overview
      • 8.4.15.2 Top Products/Product Portfolio
      • 8.4.15.3 Top Competitors
      • 8.4.15.4 Target Customers
      • 8.4.15.5 Key Personnel
      • 8.4.15.6 Analyst View
    • 8.4.16 Bioteke Corporation
      • 8.4.16.1 Overview
      • 8.4.16.2 Top Products/Product Portfolio
      • 8.4.16.3 Top Competitors
      • 8.4.16.4 Target Customers
      • 8.4.16.5 Key Personnel
      • 8.4.16.6 Analyst View

9 Research Methodology

  • 9.1 Data Sources
    • 9.1.1 Primary Data Sources
    • 9.1.2 Secondary Data Sources
    • 9.1.3 Data Triangulation
  • 9.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Nucleic Acid Sample Preparation Instruments Market (by Scenario), $Million, 2024, 2030, and 2035
  • Figure 2: Global Nucleic Acid Sample Preparation Instruments Market (by Region), $Million, 2024, 2030, and 2035
  • Figure 3: Global Nucleic Acid Sample Preparation Instruments Market (by Product Type), $Million, 2024, 2030, and 2035
  • Figure 4: Global Nucleic Acid Sample Preparation Instruments Market (by Technology), $Million, 2024, 2030, and 2035
  • Figure 5: Global Nucleic Acid Sample Preparation Instruments Market (by Throughput), $Million, 2024, 2030, and 2035
  • Figure 6: Global Nucleic Acid Sample Preparation Instruments Market (by End User), $Million, 2024, 2030, and 2035
  • Figure 7: Global Nucleic Acid Sample Preparation Instruments Market, $Million, 2018-2035
  • Figure 8: Regional Estimate of Tuberculosis Incidence, Thousands, 2023
  • Figure 9: Global Nucleic Acid Sample Preparation Instruments Market (by Product Type), $Million, 2024, 2030, and 2035
  • Figure 10: Growth-Share Analysis for Global Nucleic Acid Sample Preparation Instruments Market (by Product Type), 2024-2035
  • Figure 11: Global Nucleic Acid Sample Preparation Instruments Market (Nucleic Acid Extraction Systems), $Million, 2024-2035
  • Figure 12: Global Nucleic Acid Sample Preparation Instruments Market (Nucleic Acid Extraction Systems), Units, 2024-2035
  • Figure 13: Global Nucleic Acid Sample Preparation Instruments Market (Sample Disruption and Homogenization Instruments), $Million, 2024-2035
  • Figure 14: Global Nucleic Acid Sample Preparation Instruments Market (Sample Disruption and Homogenization Instruments), Units, 2024-2035
  • Figure 15: Global Nucleic Acid Sample Preparation Instruments Market (Liquid Handling and Automation Systems), $Million, 2024-2035
  • Figure 16: Global Nucleic Acid Sample Preparation Instruments Market (by Technology), $Million, 2024, 2030, and 2035
  • Figure 17: Growth-Share Analysis for Global Nucleic Acid Sample Preparation Instruments Market (by Technology), 2024-2035
  • Figure 18: Global Nucleic Acid Sample Preparation Instruments Market (Automated Spin-Column based), $Million, 2024-2035
  • Figure 19: Global Nucleic Acid Sample Preparation Instruments Market (Automated Spin-Column based), Units, 2024-2035
  • Figure 20: Global Nucleic Acid Sample Preparation Instruments Market (Magnetic Bead Based), $Million, 2024-2035
  • Figure 21: Global Nucleic Acid Sample Preparation Instruments Market (Magnetic Bead Based), Units, 2024-2035
  • Figure 22: Global Nucleic Acid Sample Preparation Instruments Market (Automated Liquid Handling), $Million, 2024-2035
  • Figure 23: Global Nucleic Acid Sample Preparation Instruments Market (by Throughput), $Million, 2024, 2030, and 2035
  • Figure 24: Growth-Share Analysis for Global Nucleic Acid Sample Preparation Instruments Market (by Throughput), 2024-2035
  • Figure 25: Global Nucleic Acid Sample Preparation Instruments Market (Low-Throughput Instruments), $Million, 2024-2035
  • Figure 26: Global Nucleic Acid Sample Preparation Instruments Market (Low-Throughput Instruments), Units, 2024-2035
  • Figure 27: Global Nucleic Acid Sample Preparation Instruments Market (Medium-Throughput Instruments), $Million, 2024-2035
  • Figure 28: Global Nucleic Acid Sample Preparation Instruments Market (Medium-Throughput Instruments), Units, 2024-2035
  • Figure 29: Global Nucleic Acid Sample Preparation Instruments Market (High-Throughput Instruments), $Million, 2024-2035
  • Figure 30: Global Nucleic Acid Sample Preparation Instruments Market (High-Throughput Instruments), Units, 2024-2035
  • Figure 31: Global Nucleic Acid Sample Preparation Instruments Market (by End User), $Million, 2024, 2030, and 2035
  • Figure 32: Growth-Share Analysis for Global Nucleic Acid Sample Preparation Instruments Market (by End User), 2024-2035
  • Figure 33: Global Nucleic Acid Sample Preparation Instruments Market (Academic Research Institute), $Million, 2024-2035
  • Figure 34: Global Nucleic Acid Sample Preparation Instruments Market (Academic Research Institute), Units, 2024-2035
  • Figure 35: Global Nucleic Acid Sample Preparation Instruments Market (Pharmaceutical and Biotechnology Companies), $Million, 2024-2035
  • Figure 36: Global Nucleic Acid Sample Preparation Instruments Market (Pharmaceutical and Biotechnology Companies), Units, 2024-2035
  • Figure 37: Global Nucleic Acid Sample Preparation Instruments Market (Clinical Diagnostic Centers), $Million, 2024-2035
  • Figure 38: Global Nucleic Acid Sample Preparation Instruments Market (Clinical Diagnostic Centers), Units, 2024-2035
  • Figure 39: Global Nucleic Acid Sample Preparation Instruments Market (Applied Testing (Biobanks, Forensic and Veterinary Laboratories)), $Million, 2024-2035
  • Figure 40: Global Nucleic Acid Sample Preparation Instruments Market (Applied Testing (Biobanks, Forensic and Veterinary Laboratories)), Units, 2024-2035
  • Figure 41: Global Nucleic Acid Sample Preparation Instruments Market (Contract Research Organizations), $Million, 2024-2035
  • Figure 42: Global Nucleic Acid Sample Preparation Instruments Market (Contract Research Organizations), Units, 2024-2035
  • Figure 43: North America Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 44: U.S. Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 45: Canada Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 46: Europe Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 47: Germany Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 48: U.K. Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 49: France Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 50: Italy Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 51: Spain Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 52: Netherlands Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 53: Poland Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 54: Portugal Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 55: Russia Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 56: Rest-of-Europe Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 57: Asia Pacific Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 58: Australia Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 59: China Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 60: India Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 61: Japan Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 62: Malaysia Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 63: South Korea Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 64: Thailand Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 65: Taiwan Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 66: Singapore Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 67: Indonesia Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 68: Philippines Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 69: Rest-of-Asia-Pacific Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 70: Latin America Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 71: Argentina Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 72: Brazil Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 73: Chile Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 74: Mexico Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 75: Colombia Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 76: Rest-of-Latin America Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 77: Middle East and Africa Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 78: Saudi Arabia Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 79: South Africa Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 80: U.A.E Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 81: Rest-of-Middle East and Africa Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 82: Company Share Analysis, Nucleic Acid Sample Preparation Instruments (Nucleic Acid Extraction Systems and Sample Disruption and Homogenization Instruments) Market
  • Figure 83: Data Triangulation
  • Figure 84: Top-Down and Bottom-Up Approach
  • Figure 85: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Global Nucleic Acid Sample Preparation Instruments Market, Market Attractiveness
  • Table 3: Global Nucleic Acid Sample Preparation Instruments Market Regulatory Landscape in the U.S., EU, Japan, China, and India
  • Table 4: Pricing of Nucleic Acid Sample Preparation Instruments by Product (Nucleic Acid Extraction Systems)
  • Table 5: Pricing of Nucleic Acid Sample Preparation Instruments by Product (Liquid Handling and Automation Systems)
  • Table 6: Pricing of Nucleic Acid Sample Preparation Instruments by Product (Sample Disruption & Homogenization Instruments)
  • Table 7: Impact Analysis of Market Dynamics, 2024-2035
  • Table 8: Low-Throughput Instruments
  • Table 9: Medium-Throughput Instruments
  • Table 10: High-Throughput Instruments
  • Table 11: Global Nucleic Acid Sample Preparation Instruments Market (by Region), $Million, 2024-2035
  • Table 12: Nucleic Acid Sample Preparation Instruments Market, Product Benchmarking (by Product Type)
  • Table 13: Partnerships, Collaborations, and Business Expansions
  • Table 14: New Offerings